Mahta Binayao, MD
Obstetrics & Gynecology · Austin, TXNPI 1285045195
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $8,141 with a category attached, or 73.7%. Intuitive Surgical accounts for 74.2% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $6,312 and has fallen 97.7% since, to $144 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $89.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Exeltis, USA Inc.$360
- Mayne Pharma Commercial LLC$253
- AbbVie$209
- Shield Therapeutics Inc$165
- Organon$157
- plus $957 from 18 others
What the payments were for
- Food & beverage$2,14126%
- Education$6,00074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $6,040 |
| Exeltis, USA Inc. | 18 | $360 |
| Mayne Pharma Commercial LLC | 12 | $253 |
| AbbVie | 11 | $209 |
| Shield Therapeutics Inc | 5 | $165 |
| Organon | 7 | $157 |
| Exact Sciences | 6 | $141 |
| Davol Inc. | 2 | $138 |
| Pacira Pharmaceuticals Incorporated | 2 | $137 |
| Astellas Pharma US Inc | 2 | $133 |
| Evofem Biosciences, Inc. | 5 | $99 |
| Biogen | 2 | $40 |
| Meditrina | 2 | $39 |
| Pfizer | 2 | $38 |
| Merck | 2 | $29 |
| Acessa Health Inc. | 2 | $24 |
| Myriad Women's Health, Inc. | 1 | $23 |
| Avanos Medical | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Innovation Technologies Inc | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $16 |
| Aspira Women's Health Inc | 1 | $14 |
| Millicent US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,000
- Veozah$125
- ARISTA AH FLEXITIP$123
- Slynd$120
- EXPAREL$118
How this compares
$8,141 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $475 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.